Hongchao L. Zhen

No. 45 Gong Chen North Street, Funhill District
Gongchen, 102400, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Navigating Immunotherapy Resistance: The Role of Cross-Line Strategies in Cancer Treatment.

Navigating Immunotherapy Resistance: The Role of Cross-Line Strategies in Cancer Treatment.

Journal: Journal of clinical medicine

Published: February 13, 2026

Exploring the Regulatory Effects of Curcumin on CD47-Overexpressing Esophageal Cancer Cells via Network Pharmacology with Preclinical Validation.

Exploring the Regulatory Effects of Curcumin on CD47-Overexpressing Esophageal Cancer Cells via Network Pharmacology with Preclinical Validation.

Journal: Current medicinal chemistry

Published: July 27, 2025

Inosine enhances the efficacy of immune-checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study.

Inosine enhances the efficacy of immune-checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study.

Journal: Cancer medicine

Published: November 19, 2023

Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature.

Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature.

Journal: Journal of cancer research and clinical oncology

Published: July 15, 2023

Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets.

Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets.

Journal: Journal of translational medicine

Published: January 17, 2023

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.

Journal: BMC cancer

Published: October 17, 2022

Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.

Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.

Journal: BMC cancer

Published: December 24, 2021

Decreased expression of Dlg5 is associated with a poor prognosis and epithelial-mesenchymal transition in squamous cell lung cancer.

Decreased expression of Dlg5 is associated with a poor prognosis and epithelial-mesenchymal transition in squamous cell lung cancer.

Journal: Journal of thoracic disease

Published: June 24, 2021

Clinical observation of the efficacy of PD-1/PD-L1 inhibitors in the treatment of patients with advanced solid tumors.

Clinical observation of the efficacy of PD-1/PD-L1 inhibitors in the treatment of patients with advanced solid tumors.

Journal: Immunity, inflammation and disease

Published: May 17, 2021

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis.

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis.

Journal: Frontiers in oncology

Published: December 22, 2020

Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.

Raltitrexed Enhances the Antitumor Effect of Apatinib in Human Esophageal Squamous Carcinoma Cells via Akt and Erk Pathways.

Journal: OncoTargets and therapy

Published: August 13, 2020

Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer.

Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer.

Journal: BMC gastroenterology

Published: October 16, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026